F. Schindel
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation
Papers in
-
- Phytochemical Studies and Bioactivities 2
- Glycosylation and Glycoproteins Research 1
-
- Hemophilia Treatment and Research 1
- Co-authors
- Sigurd Knaub (3 shared papers)H. Heinrichs (4 shared papers)Steven M. Opal (1 shared paper)Alain Eid (2 shared papers)Ivan Novák (2 shared papers)Heinz-Otto Keinecke (1 shared paper)István Pénzes (2 shared papers)S. Pillay (2 shared papers)
- Journals
- Transplant International (2 papers)JAMA (2 papers)Haemophilia (1 paper)Annals of Allergy Asthma & Immunology (1 paper)Intensive Care Medicine (1 paper)
- Partner nations
- GermanySwedenUnited States
In The Last Decade
F. Schindel
11 papers receiving 1.1k citations
F. Schindel's Hit Papers
Peers
Comparison fields: 5 of 88
- Internal Medicine 153
- Critical Care and Intensive Care Medicine 207
- Hematology 319
- Epidemiology 593
- Nephrology 62
Countries citing papers authored by F. Schindel
This map shows the geographic impact of F. Schindel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Schindel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Schindel more than expected).
Fields of papers citing papers by F. Schindel
This network shows the impact of papers produced by F. Schindel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Schindel. The network helps show where F. Schindel may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Schindel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | High-Dose Antithrombin III in Severe Sepsis Hit paper breakdown → | 2001 | 947 |
| 2 | 2004 | 49 | |
| 3 | 2000 | 46 | |
| 4 | 1993 | 29 | |
| 5 | 2003 | 26 | |
| 6 | 2010 | 24 | |
| 7 | 1996 | 17 | |
| 8 | 1994 | 15 | |
| 9 | 1994 | 14 | |
| 10 | 2000 | 12 | |
| 11 | High-dose a randomized antithrombin III in severe sepsis - A randomized controlled trial. | 2001 | 2 |
| 12 | 1991 | 0 | |
| 13 | Clinical evaluation of erythropoietin (EPO) in oncology. | 1991 | 0 |
About F. Schindel
F. Schindel is a scholar working on Molecular Biology, Hematology, Cell Biology, Statistics and Probability and Surgery, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (2 papers), Phytochemical Studies and Bioactivities (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Hemophilia Treatment and Research (1 paper), Glycosylation and Glycoproteins Research (1 paper), Advanced Causal Inference Techniques (1 paper) and Multi-Criteria Decision Making (1 paper). The work is most often cited by research in Internal Medicine (153 citations), Critical Care and Intensive Care Medicine (207 citations), Hematology (319 citations), Epidemiology (593 citations) and Nephrology (62 citations). F. Schindel has collaborated with scholars based in Germany, Sweden and United States. Frequent co-authors include Sigurd Knaub, H. Heinrichs, Steven M. Opal, Alain Eid, Ivan Novák, Heinz-Otto Keinecke, István Pénzes, S. Pillay, Brian Warren and A Kübler. Their work appears in journals such as Transplant International, JAMA, Haemophilia, Annals of Allergy Asthma & Immunology and Intensive Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.